Method and product for cleaning and/or whitening of teeth

Patent Citations (10)

Non-Patent Literature (35)

• Lyon, Jr. et al., “Evaluation of Effects of Application of a Citroxain-Containing Dentrifice,” 3 J. Esthetic Dentistry 51-53 (1991).Applicant
• Kirschke et al., Lysomal Cysteine Proteinases (2d ed. 1998).Applicant
• Abrahamson, “Human Cysteine Proteinase Inhibitors,” ?Scand. J. Clin. Lab. Invest. Suppl. 191: 21-23 (1988).Applicant
• Bromme et al., “Tight-binding Inhibition of Cathepsin S by Cystatins,” 50 Biomed. Biochim.Acta 4-6, 631-635 (1991).Applicant
• Saettone et al., “Evaluation of Muco-adhesive Properties and In Vivo Activity of Opthalmic Vehicles Based On Hyaluronic Acid,” 51 Int. J. Pharmaceutics 203-212 (1989).Applicant
• Lee et al., “Ocular Drug Bioavailability From Topically Applied Liposomes,” 29 Survey of Ophthalmology 335-348 (1985).Applicant
• Longer et al., “Fundamental Aspects of Bioadhesion,” 7 Phar. Int. 114-117 (1986).Applicant
• Hui et al., “Ocular Delivery of Progesterone Using A Bioadhesive Polymer,” 26 Int. J. Pharmaceutics 203-213 (1985).Applicant
• Bjorck et al., “Bacterial Growth Blocked By A Synthetic Peptide Based on the Structure of a Human Proteinase Inhibitor,” 337 Nature 385 (1989).Applicant
• Meisner et al., “Liposmal Ophthalmic Drug Delivery. III. Pharmacodynamic and Biodisposition Studies of Atropine,” 55 Int. J. Pharmaceutics 105-113 (1989).Applicant
• Barber et al., “Tear-induced Release of Liposome-entrapped Agents,” 60 Int. J. Pharmaceutics 219-227 (1990).Applicant
• Suominen et al., “Cathepsin B′ in the Thyroid Gland,” 25 Acta. Chem. Scand. 2531 (1971).Applicant
• Rinne et al., “Demonstration of Cathepsins H and L in Rat Tissues,” 45 Biomed. Biochim. Acta. 1465-1476 (1986).Applicant
• Nakamura et al., “An Endogenous Inhibitor of Calcium-activated Neutral Proteinases in UMX 7.1 Hamster Dystrophy,” 14 Muscle & Nerve 701-708 (1991).Applicant
• Hayashi, “The Intracellular Neutral SH-Dependent Protease Associated With Inflammatory Reactions,” 40 Int. Rev. Cytol. 101-151 (1975).Applicant
• Rinne et al., “Uber das Vorkommen des Epidermalen SH-Proteases-Inhibitors im Lymphatischen Gewebe,” 75 Verh. Anat. Ges. 573-74 (1981).Applicant
• Isemura et al., “Characterization and Amino Acid Sequence of a New Acidic Cysteine Proteinase Inhibitor (Cystatin SA) Structurally Closely Related to Cystatin S, From Whole Human Saliva,” 102 J. Biochem. 693-704 (1987).Applicant
• Jarvinen et al., “Partial Purification and Some Properties of a New Papain Inhibitor From Psoriatic Scales,” 82 J. Invest. Dermatol. 471-476 (1984).Applicant
• Rinne, “Cystatin A,” Human Protein Data 3 Installment (A. Haeberli ed. 1995).Applicant
• Bjorck et al., “Cystatin C, A Human Proteinase Inhititor, Blocks Replication of Herpes Simplex Virus,” 64 J. Virol 941-943 (1990).Applicant
• Smolin et al., “Idoxuridine-liposome Therapy for Herpes Simplex Keratitis,” 91 Am. J. Ophthalmol. 220-225 (1981).Applicant
• Guo et al., “Bioadhesive Liposomes in Ophthalmic Delivery,” 28 Invest. Ophthalmol Vis. Sci. Supp. 72 (1987).Applicant
• Finne, “Basic Salts Modify Timolol Delivery in Ocular Inserts of Alkyl Monesters of Poly(vinyl methyl ether-maleic anhydride),” Univ. Kupio Research Reports 15 (1991).Applicant
• Lahdes, “Systemic Absorption and Effects of Topically Applied Ocular Anticholinergic Drugs,” Annales Universitatis Turkuensis Ser. D, Tom. 218 (1996).Applicant
• Huupponen et al., “The Effect of Some Macromolecular Ionic Complexes on the Pharmaco-kinetics and dynamics of Ocular Cyclopentolate In Rabbits,” 8 J. Ocul. Pharmacol. 59-67 (1992).Applicant
• Kupferman et al., “Prolongation of Anti-Inflammatory Effect of Prednisolone Acetate. Influence of Formulation in High Viscosity Gel,” 99 Arch. Ophthalmol. 2028-2029 (1981).Applicant
• Lewis et al., “Ethoxzolamide Analogue Gel. A Topical Carbonic Anhydrase Inhibitor,” 102 Arch. Ophthamol. 1821-1824 (1984).Applicant
• Kirschke et al., “Cathepsin S From Bovine Spleen. Purification, Distribution, Intracellular Localization and Action on Proteins,” 264 J. Biochem. 467-473 (1989).Applicant
• Jarvinen et al., “Human Spleen Cysteine Proteinase Inhibitor. Purification, Fractionation Into Isolelectric Variants and Some Properties of the Variants.” 708 Biochim. Biophys. Acta. 210-217 (1982).Applicant
• Jarvinen et al. “Alpha-N-Benzoylarginine-2-Naphthylamide Hydrolase (Cathepsin B?) From Rat Skin. II. Purification of the Enzyme and Demonstration of Two Inhibitors in the Skin,” 29 Acta. Chem. Scand. B 772-780 (1975).Applicant
• Green et al., “Cystatin-like Cysteine Proteinase Inhibitors From Human Liver,” 218 J. Biochem. 939-946 (1984).Applicant
• Rinne, “Epidermal SH-proteinase Inhibitor. Occurrence in Human and Rat Tissues and in Human Neoplasms,” Acta. Univ. Ouluensis Ser. D, Medica No. 41 (1979).Applicant
• Rinne et al., “Cystatin B,” Human Protein Data 3 Installment (A. Haeberli ed. 1995).Applicant
• Davies et al., “Immunolocalization of Human Cystatins in Neutrophils and Lymphocytes,” 80 Histochemistry 373-377 (1984).Applicant
• Bjorklund et al., “Rhabdovirus-Induced Apoptosis in a Fish Cell Line is Inhibited by a Human Endogenous Acid Cysteine Proteinase Inhibitor,” 71 J. Virol . 5658-5662 (1997).Applicant